# ChatTogoVar

There is no direct evidence from the TogoVar API data suggesting that the variant **rs1170153450** is associated with drug metabolism or drug response. Below is all relevant information regarding the variant:

### 1-1. Variant Information
- **RS Number**: [rs1170153450](https://identifiers.org/dbsnp/rs1170153450)
- **Gene Name**: Two genes are associated with this variant:
  - **ASCL1** (also known as ASH1, HASH1, bHLHa46)
  - **PAH** (Phenylalanine Hydroxylase)
- **Transcript Info**:
  - **ASCL1**: ENST00000266744.4:c.2T>A (p.Met1?)
  - **PAH**: 
    - ENST00000547319.1:n.165A>T
    - ENST00000551337.5:c.-147A>T

### 1-2. Relationship with Diseases and Functional Predictions
- **ClinVar**: No curated information is available linking this variant to diseases or drug-related traits.
- **AlphaMissense**: No prediction data provided.
- **SIFT**: Predicted to have a damaging effect (score: 0.0).
- **Polyphen**: Prediction status is unknown.

### 1-3. Literature
There is no specific mention of **rs1170153450** in the context of drug metabolism or response in the literature accessible through this query.

### 1-4. Population Frequency
- **gnomAD**: Minor allele frequency (MAF): 6.58×10⁻⁶ in genomes.
- **NCBN (Japanese dataset)**: MAF: 4.28×10⁻⁵.
This indicates a slightly higher frequency in the Japanese population than in gnomAD populations, but there is no evidence associating this variant with specific traits in these populations.

### 1-5. GWAS Data
Currently, no genome-wide association studies (GWAS) have linked **rs1170153450** to drug metabolism, drug response, or related phenotypes.

### 1-6. TogoVar Link
For more details, you can access the [TogoVar page for rs1170153450](https://togovar.biosciencedbc.jp).

---

### Conclusion
There is no concrete evidence or existing data from TogoVar API or other sources suggesting an association between **rs1170153450** and drug metabolism or drug response. Further investigation might be required for more clarity.